Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EU reviews first PARP inhibitor for breast cancer

pharmatimesJuly 18, 2018

Tag: Lynparza , PARP inhibitor , Breast Cancer , ovarian cancer

PharmaSources Customer Service